Zynerba Pharmaceuticals Inc - Real-time stock metrics, market data, and comprehensive analysis
Fetching stock data...
Zynerba Pharmaceuticals is the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders. We are committed to improving the lives of patients and their families living with severe, chronic health conditions including Fragile X syndrome and 22q11.2 deletion syndrome.
No news available